Ji, Lijuan <br/><br/>
Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.  [electronic resource] 

 -  Medical science monitor : international medical journal of experimental and clinical research  Aug 2019 
 - 5823-5832 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1643-3750 
<br/><br/><label>Standard No.: </label>10.12659/MSM.915754  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Hepatocellular--genetics<br/>Cell Movement--genetics<br/>Cell Proliferation--genetics<br/>Epithelial-Mesenchymal Transition--genetics<br/>Female<br/>Gene Expression--genetics<br/>Gene Expression Regulation, Neoplastic--genetics<br/>Glycine Hydroxymethyltransferase--genetics<br/>Hep G2 Cells<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--genetics<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Transcriptome--genetics